Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
86 participants
INTERVENTIONAL
2011-11-01
2018-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Closure of Protective Ileostomy in Rectal Cancer Patients
NCT02997267
Early Closure of Temporary Ileostomy
NCT01287637
Early Closure Versus Conventional Closure in Postoperative Patients With Low Anteriresection for Rectal Cancer
NCT03746353
The Effects of Temporary Ileostomy on Outcome in Patients With Rectal Cancer
NCT06391385
Early Ileostomy Closure for Rectal Cancer Patients in North America
NCT05027737
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early closure of preventive ileostomy
A preventive ileostomy is closed 30 days after the primary surgery
Deileostomy
Deileostomy
Late closure of preventive ileostomy
A preventive ileostomy is closed 90 days after the primary surgery
Deileostomy
Deileostomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Deileostomy
Deileostomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients willing to participate in the study
Exclusion Criteria
* Patients, who are physically and mentally unfit to undergo surgery or to be followed-up
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vilnius University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rimantas Bausys
Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Cancer Institute
Vilnius, , Lithuania
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.